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Abstract
Background & Aims
Hydrogen sulphide (H2S), nitric oxide (NO), and carbon monoxide (CO) are involved in tran-
sitional microvascular tone dysregulation in the preterm infant; however there is conflicting
evidence on the interaction of these gasotransmitters, and their overall contribution to the
microcirculation in newborns is not known. The aim of this study was to measure the levels
of all 3 gasotransmitters, characterise their interrelationships and elucidate their combined
effects on microvascular blood flow.
Methods
90 preterm neonates were studied at 24h postnatal age. Microvascular studies were per-
formed by laser Doppler. Arterial COHb levels (a measure of CO) were determined through
co-oximetry. NO was measured as nitrate and nitrite in urine. H2S was measured as thiosul-
phate by liquid chromatography. Relationships between levels of the gasotransmitters and
microvascular blood flow were assessed through partial correlation controlling for the influ-
ence of gestational age. Structural equation modelling was used to examine the combina-
tion of these effects on microvascular blood flow and derive a theoretical model of
their interactions.
Results
No relationship was observed between NO and CO (p = 0.18, r = 0.18). A positive relation-
ship between NO and H2S (p = 0.008, r = 0.28) and an inverse relationship between CO
and H2S (p = 0.01, r = -0.33) exists. Structural equation modelling was used to examine the
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combination of these effects on microvascular blood flow. The model with the best fit
is presented.
Conclusions
The relationships between NO and H2S, and CO and H2S may be of importance in the pre-
term newborn, particularly as NO levels in males are associated with higher H2S levels and
higher microvascular blood flow and CO in females appears to convey protection against
vascular dysregulation. Here we present a theoretical model of these interactions and their
overall effects on microvascular flow in the preterm newborn, upon which future mechanistic
studies may be based.
Introduction
Endogenous hydrogen sulphide (H2S) is associated with microvascular tone regulation at 24h
postnatal age in the preterm infant and production appears to be affected by both gestational
age and sex [1]. Nitric oxide (NO) and carbon monoxide (CO) also play a crucial role in the
transitional circulation of preterm neonates [2,3]. NO is proposed to play a central role in the
maintenance of vascular homeostasis in the perinatal period, however urinary excretion of NO
metabolites do not correlate with early changes in microvascular blood flow in the preterm ne-
onate [4]. It has been hypothesised that the rate of NO production in the endothelium of pe-
ripheral microvessels (via endothelial nitric oxide synthase (eNOS)) is lower than would be
required to activate the downstream sGC pathway in vascular smooth muscle cells responsible
for the excessive vasodilatation seen in premature neonates. This has led to the speculation that
other mechanisms may be involved in both the production of NO in the microvasculature and
its vasoactive effects on vascular smooth muscle cells during the transition from fetal to neona-
tal circulatory systems, with NO contributing to the maintenance of background tone through-
out this period [5,6]. CO levels, on the other hand, correlate with both gestational age and
microvascular blood flow at 24h postnatal age, suggesting that CO production by very preterm
neonates may contribute to their increased risk of microvascular dysfunction and physiological
instability [4].
The interaction of these gasotransmitters may account for a large proportion of their action.
For example, NO and CO interact in the neonatal cerebral vasculature to regulate vascular tone
—acute elevation in CO produces vasodilatation, yet prolonged production inhibits NO pro-
duction, causing cerebrovascular constriction. Knecht et al. [7], hypothesised this interaction
between CO and NOmay form the basis of a negative feedback system in the control of cere-
brovascular tone. However, the interaction between NO and CO, and between these two sys-
tems and H2S may not be as simple as this. A number of studies examining the relationship
between the gasotransmitters have been published, with conflicting results. The different find-
ings reported by these various studies may be due to differences in the tissues studied, the ani-
mal studied and/or their developmental stage and the methods used [8,9,10]. Some of these
findings are summarised in Table 1. Whilst this is not an exhaustive list of all studies examining
the interactions between the gasotransmitters, it gives some idea of the wide-ranging results ob-
served in a number of discrete studies.
The synergistic effect of the interactions between these gasotransmitters arises from their
different signalling cascades and their ability to enhance or diminish the effects of one or more
of the others. The aim of the present study was to establish theoretical models of the
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Table 1. Published Interactions of the Gasotransmitters.
Effector Interaction Tissue Species Developmental
Stage
Reference(s)
Nitric Oxide
" HO-1 expression (protein) Aortic endothelial cells Bovine [11]
" CO production and action Cerebral vessels (pial arterioles) Pig Neonatal [12,13,14]
" CO action (permissive enabler) Retina Salamander [15]
" CO, " HO-1 expression (protein,
mRNA)
Aortic smooth muscle cells Rat [16]
" CO, " HO-1 expression Mesangial cells Rat [17]
" CO, " HO-1 expression Fibroblasts (from lung) Human Embryonic [18]
" CO, " HO-1 expression Kidney epithelial cells (cell line: LLC-PKI) Pig Juvenile (male) [19]
" CO, " HO-1 expression Macrophages (cell line: RAW264.7)1 Mouse [20]
# CO (via HO-1 inhibition) Puriﬁed proteins Human [21]
# HO activity Aortic endothelial cells (cell line: AG08472) Pig [22]
# HO-2 activity Puriﬁed proteins Rat [23]
" CSE expression Peritoneal macrophages Mouse Adult (male) [24]
" H2S, " CSE expression Aorta Rat Adult (male) [25]
# CBS activity Puriﬁed Proteins Human [26,27]
Carbon Monoxide
" NO release Pulmonary artery endothelial cells Bovine [28]
" NO release (at low concentrations of
CO)
Renal arteries Rat Adult (male) [29]
# NO, # eNOS (at high concentrations
of CO)
Renal arteries Rat Adult (male) [29]
# NO (via NOS inhibition) after
prolonged elevation of CO
Cerebral vessels (pial arterioles) Pig Neonatal [7]
# NO (via NOS inhibition) HO-1, HO-2 constructs Rat [23]
# NOS Cerebellum (granule cells) Rat Neonate [30]
# iNOS activity, # nNOS activity Macrophages (iNOS), cerebellum (nNOS) Rat [31]
# iNOS expression (transcriptional
level)
Astrocytes Human Fetal [32]
# nNOS activity Cerebellum (granule cells) Rat Neonatal [33]
# H2S (via CBS inhibition) Astrocytes Mouse Neonatal [34]
# H2S, # CSE expression Aortic smooth muscle cells Rat Juvenile (male) [35]
# H2S (via CSE inhibition) Carotid body Mouse, rat Adult (male) [36]
Hydrogen Sulphide
" NO release Brain homogenates Rat [37]
" NO action (permissive enabler) Ileum, aorta Guinea Pig,
Rat
Juvenile [38,39]
# NO effect Aorta Rat [40]
# NO Retina Salamander [15]
# NO activity Aorta Rat Adult (male) [41]
# NO, # iNOS Macrophages (cell line: RAW264.7;
lipopolysaccharide exposed)1
Mouse [42]
# eNOS Aorta Mouse, rat Juvenile (male) [43]
# eNOS, # nNOS, # iNOS Recombinant proteins [44]
" CO, " HO-1 expression (protein,
mRNA)
Pulmonary arteries (with induced hypoxic
pulmonary hypertension)
Rat Juvenile (male) [45]
(Continued)
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interactions of the gasotransmitters and their combined effects on blood flow in the preterm
newborn. This would provide a framework for establishing and testing current and future
mechanistic hypotheses in this population. In order to achieve this, we measured the levels of
all three gasotransmitters in the one neonatal population and characterised the interrelation-
ships between NO, CO and H2S using structural equation modelling. As the differences in CO
and H2S independently only account for a proportion of the vascular dysfunction observed in
preterm neonates at 24h postnatal age we hypothesised that the interactions of NO, CO and
H2S would account for a greater proportion of the microvascular tone dysregulation observed
in the preterm newborn than the investigation of each of these molecules in isolation.
Methods
Subjects
Neonates 24–36 weeks’ gestation (n = 96) were studied at 24h postnatal age as part of the
Cardiovascular Adaptation of the Newborn Study 2 (CANS2). These neonates form part of the
cohort reported on previously [1,46]. Hypoxic ischemic encephalopathy, congenital malforma-
tions, chromosomal disorders or known congenital infection excluded admission to this study.
The study protocol was approved by the human ethics committees at John Hunter Hospital
and the University of Newcastle. Parental informed, written consent was obtained prior
to investigation.
Microvascular studies
Investigations were performed at 24h postnatal age with a Periflux 5001 laser Doppler (Peri-
med AB, Jarfalla, Sweden) with a temperature-regulated probe (Probe 457, Perimed) set at
36°C sited on the lateral aspect of the neonates’ lower limb as previously described [46].
Clinical Illness severity
Clinical illness severity was evaluated using the Clinical Risk Index for Babies (CRIB) II scoring
system [47].
Carbon monoxide measurement
CO binds competitively to haemoglobin, in preference to oxygen, to form carboxyhaemoglobin
(COHb), which represents an in vivo sink for CO. Arterial COHb levels were determined at
24h postnatal age through spectrophotometry by using an ABL700 blood gas analyzer (Radi-
ometer, Copenhagen, Denmark) and expressed as a proportion of total haemoglobin concen-
tration as previously described [4].
Table 1. (Continued)
Effector Interaction Tissue Species Developmental
Stage
Reference(s)
# CO, # HO-1 expression (protein) Aortic smooth muscle cells Rat Juvenile (male) [35]
HO heme oxygenase; CSE cystathionine-γ-lyase; CBS cystathionine-β-synthase; NOS nitric oxide synthase (eNOS endothelial isoform, iNOS inducible
isoform, nNOS neuronal isoform). 1leukaemic monocyte macrophage cell line.
doi:10.1371/journal.pone.0121621.t001
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Urine collection
24-hour urine samples were collected on day 2 of postnatal life as previously described [48].
Exact 24-hour urinary output was calculated by weighing diapers before and after use. As hu-
midity can contribute to diaper weight, the degree and length of time in humidity were re-
corded and adjustments were made to calculate “true” increase as previously described [49].
Nitrate/nitrite measurement
NO has a short physiological half-life, making it difficult to measure directly. In order to assess
total body turnover of NO, the more stable end products of NO oxidation, nitrate and nitrite,
were measured in urine using a commercially available colorimetric assay according to manu-
facturer’s instructions (Cayman Chemical Company, Ann Arbor, USA). Nitrate/nitrite levels
were adjusted for 24h output and body weight to give a measure of total body output/24h
(nmol/24h/kg).
Thiosulphate measurement
Thiosulphate, a stable urinary metabolite of H2S was used to assess total body turnover of H2S,
due to the short half-life and volatile nature of the gas. Thiosulphate was measured by re-
versed-phase liquid chromatography as previously described [1,50]. Thiosulphate levels were
adjusted for 24h output and body weight to give a measure of total body output/24h (nmol/
24h/kg).
Statistical methods
Stata 13 for MacOSX (StataCorp LP, Texas, USA) was used for statistical analyses and structur-
al equation modelling. Stata 13 and Prism 6 for MacOSX (GraphPad Software Inc., La Jolla,
CA) were used for generation of figures. Data are presented as median (range) or mean and
SEM where appropriate. Differences between groups were analysed by Mann-Whitney U-test
unless otherwise stated. The relationships between levels of CO, NO, H2S and microvascular
blood flow were assessed through partial correlation controlling for the influence of gestational
age as in our previous studies [1,4]. Structural equation modelling was then performed in order
to examine the combination of these effects on microvascular blood flow.
Structural equation modelling allows the examination of complex causal hypotheses on a
set of intercorrelated non-experimental data and can be used for both exploration and confir-
mation of theoretical models [51]. For an exploratory approach such as that presented in the
current study, a detailed model specifying the relationships among variables is not made a pri-
ori. This approach is considered superior over other correlational methods such as regression
as multiple variables are analysed simultaneously, and latent factors reduce measurement
error. When used as an exploratory or confirmatory approach, structural equation modelling
provides information about the complex nature of disease and health behaviours. This is
achieved by the examination of both direct and indirect, and unidirectional and bidirectional
relationships between measured and latent variables [52]. In our particular construct, this was
the interaction between the three gasotransmitters and their individual and combined effects
on microvascular blood flow. All possible models were manually constructed for our three
input (NO, CO and H2S) and one output (microvascular blood flow) variables. These models
were then tested and assessed for suitability by χ2 Goodness of Fit and root mean square error
of approximation (RMSEA). Lower χ2 values represent a better predicted model, whilst an
RMSEA of below 0.06 shows a good fit [53]. RMSEA also allows for the calculation of a confi-
dence interval (CI) around the predictive value of the model [54].
Gasotransmitter Interactions in the Preterm Neonate
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Results
Of the 96 preterm neonates in the cohort, 6 neonates did not have complete data and could not
be included in the model. Physical and clinical characteristics, including microvascular blood
flow measurements for the remaining 90 neonates included in the model are reported in
Table 2.
Consistent with our previously reported observations in this cohort of neonates, which in-
cluded the 96 preterm neonates (as well as 42 term neonates)) [46], microvascular blood flow
at 24h postnatal age correlated with gestational age in this subset of neonates (all neonates
p<0.0001, r = -0.54; females p = 0.009, r = -0.41; males p<0.0001, r = -0.64). There was no ef-
fect of birth weight on baseline microvascular blood flow when gestational age was accounted
for (all neonates p = 0.82, r = -0.03; females p = 0.36, r = -0.15; males p = 0.66, r = 0.07). De-
tailed microvascular blood flow data for this cohort of neonates has been previously published
[46].
Gasotransmitter measurement
NO levels were higher in females than males (females 21.4(4.6–37.1)nmol/24h/kg vs males
20.1(0.9–56.7)nmol/24h/kg, p = 0.058). No differences in CO levels between sexes were ob-
served (females 1.5(0.9–4.1)% vs. males 1.4(0.9–2.2)%, p = 0.29). Thiosulphate levels have been
previously reported for this cohort [1].
Interactions of the Gasotransmitters and their relationship with
microvascular blood flow
Gestational age at birth was related to total gasotransmitter levels: gestational age was inversely
correlated with NO (p = 0.03, r = -0.24), with no differences observed between males and fe-
males. Gestational age was also inversely correlated with CO (p = 0.0003, r = -0.45) and H2S
(p = 0.02, r = -0.25). As urinary nitrates and thiosulphate are standardised to body weight, we
could not examine the relationship between birth weight and NO and H2S. For CO, there was
no effect of birth weight when gestational age was accounted for (all neonates p = 0.21, r =
-0.17; females p = 0.14, r = -0.17; males p = 0.42, r = -0.15).
Table 2. Physical Characteristics of Neonates.
Female (n = 43) Male (n = 47)
Gestational Age (weeks) 28 (24–35) 29 (24–35)
Birth Weight (kg) 1.06 (0.45–2.38) 1.27 (0.56–2.76)
Microvascular Blood Flow (PU) 43.4 (4.7–266.8) 40.4 (6.5–216.64)
Completed Antenatal Glucocorticoids (n, %) 31 (72%) 36 (77%)
APGAR score at 5 min 8 (4–10) 9 (4–10)
Clinical Risk Index for Babies II score 8 (0–15) 5 (0–16)
Mean Blood Pressure at 24h 37.5 (24–68) 38 (26–81)
Small for Gestational Age 1 (2%) 6 (13%)
Signiﬁcant patent ductus arteriosus 11 (26%) 12 (26%)
Intraventricular haemorrhage, grade 2 2 (5%) 3 (6%)
Sepsis 11 (26%) 13 (28%)
Died 4 (9%) 4 (9%)
Data presented as median (range) or number (percentage) as appropriate. PU laser Doppler
perfusion units
doi:10.1371/journal.pone.0121621.t002
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As gestational age is strongly related to the level of gasotransmitters, the relationships be-
tween levels of CO, NO, H2S and microvascular blood flow were assessed through partial corre-
lation, controlling for the influence of gestational age. We observed a significant positive
relationship between NO levels and microvascular blood flow for males but not females
(p = 0.03, r = 0.38; females p = 0.91, r = -0.02). Furthermore, there was a significant positive re-
lationship between CO levels and microvascular blood flow for males but not females (males
p = 0.03, r = 0.38; females p = 0.88, r = -0.03) and H2S and flow (males p = 0.05, r = 0.29; fe-
males p = 0.72, r = 0.06).
Again, using partial correlations in order to account for differences associated with gesta-
tional age, we found no relationship between NO and CO (p = 0.18, r = 0.18); however, we ob-
serve a positive relationship between NO and H2S (p = 0.008, r = 0.28) and an inverse
correlation between CO and H2S (p = 0.01, r = -0.33).
Structural equation modelling
Based on the results of the present study, several theoretical models were computed (S1 Data).
The overall model with the best fit (χ2 = 1.02; RMSEA = 0.017(CI 0.00–0.28)) is presented in
Fig. 1. This model had a better Goodness of Fit in females (χ2 = 0.03; RMSEA<0.0001(CI 0.00–
0.21)) than males (χ2 = 1.88; RMSEA = 0.137(CI 0.00–0.44)). In this model, NO promotes H2S
production (overall p = 0.002, z = 3.05; males p = 0.06, z = 1.88; females p<0.0001, z = 4.53),
whilst CO inhibits H2S (overall p = 0.18, z = -1.34; males p = 0.84, z = -0.20; females p<0.0001,
z = -5.39). As described above, NO levels were higher in females than males and no differences
in CO levels between sexes were observed. The net result was a slightly enhanced positive rela-
tionship of all vasodilators acting on the microvasculature in males (p = 0.006, z = 2.74) com-
pared to the effect of H2S on microvascular blood flow in isolation (model constructed without
inclusion of other gasotransmitters; p = 0.008, z = 2.67). In females, the model predicted a
lower contribution of H2S on microvascular blood flow (p = 0.905, z = -0.12) compared to the
effect of H2S in isolation (p = 0.753, z = 0.31). The model predicted covariance in the levels of
NO and CO despite a lack of any direct effect of one on the other (p = 0.362, z = 0.91), this may
reflect an effect of gestational age. CO had no direct effect on microvascular blood flow in the
model presented, however inclusion of this pathway improved goodness of fit compared to the
Fig 1. Structural equationmodel of predicted interactions of the gasotransmitters and their contribution to the regulation of microvascular blood
flow at 24h postnatal age in the preterm human. The overall model (males and females combined) is presented and has a Goodness of Fit of χ2 = 1.02
and RMSEA value of 0.017 (CI 0.00–0.28). Structural equation modelling examines linear causal relationships among variables, while simultaneously
accounting for measurement error. The measurement error, or variance, determined in the model is 0.66 for microvascular blood flow, 0.77 for hydrogen
sulphide, 0.24 for nitric oxide and 0.07 for carbon monoxide. NO was positively correlated with H2S (p = 0.002, z = 3.05). There was an inverse correlation
between CO and H2S (p = 0.18, z = -1.34). There was a significant relationship between H2S and microvascular blood flow (p = 0.012, z = 2.52) when the
input of NO and CO to H2S was included in the model.
doi:10.1371/journal.pone.0121621.g001
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same model minus this interaction (overall with CO effect χ2 = 1.02 vs without χ2 = 2.34, fe-
males with CO effect χ2 = 0.03 vs without χ2 = 0.29, males with CO effect χ2 = 1.88 vs without
χ2 = 2.67). Additionally, the inclusion of a direct effect of CO on microvascular blood flow in-
creased the effect of H2S on blood flow in the overall model (with CO effect p = 0.012, z = 2.52
vs. without p = 0.019, z = 2.34) and in males (with CO effect p = 0.006, z = 2.74 vs. without
p = 0.008, z = 2.67).
Alternate models were tested and are presented in S1 Data. None of these models had a
more acceptable χ2 or RMSEA value and CI, thus the selection of the model presented in Fig. 1.
Discussion
Structural equation modelling is sometimes referred to as “causal modelling”. However, a num-
ber of recent publications highlight that caution must be taken when interpreting the results as
causation rather than association. Beran and Vialato [52] proposed that for causation to be de-
termined via structural equation modelling the following criteria must be met: 1) there must be
an empirical association between the variables, i.e. they are significantly correlated; 2) a com-
mon cause of the two variables must have been ruled out; 3) the two variables have a theoretical
connection; and 4) that one variable precedes the other, and if the preceding variable changes,
the outcome variable also changes (and not vice versa). These requirements are unlikely to be
satisfied using non-experimental data, thus, causation cannot be definitively demonstrated.
Rather, causal inferences that inform future experimental work may be drawn. The work pre-
sented here, and the final model proposed, in fact satisfies the majority of the criteria for causa-
tion as set out by Beran and Vialato.
Firstly, the gasotransmitters and microvascular blood flow are inter-correlated: as we have
shown previously, CO [4] and H2S [1] were associated with higher microvascular blood flow in
male preterm neonates. Contrary to our previous findings, we observed a significant, positive
relationship between NO and microvascular blood flow in male preterm neonates. Further-
more, NO was positively correlated with H2S, whilst CO was inversely correlated with H2S.
Thus, criteria 1 is met. Secondly, the variables have a theoretical connection (criteria 3): the
gasotransmitters have known vasodilatory actions, and high microvascular blood flow in the
neonate is assumed to relate to a loss of peripheral vascular tone. More specifically, a number
of studies have now shown interactions between the three gasotransmitters (Table 1). Finally,
criteria 4 specifies that one variable precedes the other; in the studies presented here, the testing
of alternate models (see S1 Data) suggests that changes in CO and NO precede changes in H2S,
and not vice versa; however, experimental studies need to be performed in order to confirm
this directionality, especially considering the volume of experimental data that supports an ef-
fect of H2S on NO (Table 1 and [55]), as well as an effect of NO on H2S.
Thus, we present here a theoretical model, supported by our human observational studies,
for the regulation of microvascular tone in the preterm newborn by the action and interaction
of the gasotransmitters, which provides a construct from which future experimental studies
may work in order to understand the development of circulatory compromise in this
vulnerable population.
Interactions of the Gasotransmitters and their relationship with
microvascular blood flow
We observed a significant positive relationship between NO and H2S. Previous studies have re-
ported that NO inhibits H2S production via CBS [26,27] but induces CSE expression, and con-
sequently, H2S production via that pathway [25]. This may suggest that in the human preterm
newborn, CSE expression is significantly modulated by NO. We have evidence from our
Gasotransmitter Interactions in the Preterm Neonate
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animal model that increases in H2S associated with microvascular dysregulation are driven by
CSE-dependent mechanisms [56]. The inhibition of CSE prevents the increased H2S produc-
tion observed at 24h postnatal age in the preterm guinea pig pup, and CSE-dependent, but not
CSE-independent H2S production is associated with increased microvascular blood flow. The
relationship between NO and CSE/H2S needs to be investigated further, particularly as this ap-
pears to be associated with higher microvascular blood flow as measured by laser Doppler.
Contrary to our previous findings [4], we observed a significant, positive relationship between
NO and microvascular blood flow at 24h postnatal age in male neonates. One source of these
differing results may be the use of different methodology—in our previous papers NO metabo-
lites were standardised to creatinine to allow for comparisons between time points and sub-
jects. It has been shown, however, that creatinine may not be the best molecule for this purpose
in the neonate as levels change significantly in the transitional period [57,58].
In females, a lower contribution of H2S to microvascular tone regulation was predicted
when the other gasotransmitters were added into the model. This suggests that the effect of ei-
ther NO, CO, or both, negates the effect of H2S to such a degree that there is no net effect on
vascular tone. This may be primarily due to CO, which is inversely correlated with H2S and
may reflect an inhibitory action of CO on H2S, in line with published reports that have demon-
strated that CO decreases the production and action of H2S [34,35,36]. This is of particular in-
terest in this cohort, as females and males had comparable levels of CO, suggesting some
protective role of this molecule against inappropriate vasodilation in the female. The findings
of our current study are discrepant with our previous studies, which showed that males had
higher levels of CO and that this was associated with inappropriate peripheral microvascular
dilatation and physiological instability in the first few days of life [4]. There are a number of
possible explanations for these differences. Firstly, the infants in our original studies were
younger (median age 1 week older in the present study, with neonates up to 35 weeks included
compared to an upper age of 32 weeks in the previous study) and therefore, sicker, than the ne-
onates in the present study. Secondly, there was a much higher rate of antenatal glucocorticoid
exposure in the present study (74% in the current study compared to 59% in the previous
study).
Limitations and future research
The present study does not provide direct confirmation of the mechanisms of action, the ex-
pression of gasotransmitter-producing enzyme/s or feedback of the gaseous molecule on the
producing and/or releasing pathways. Rather, the aim of this study was to establish a theoreti-
cal model of gasotransmitter interactions in the preterm newborn, and the potential effect of
these interactions on microvascular blood flow. Given the evidence of interactions between the
three gasotransmitters in the preterm newborn population presented here, we propose future
mechanistic studies should not focus solely on one of these gasotransmitters as driving dys-
function, but rather investigate the interactions among CO, NO and H2S in this context.
It is not possible to experimentally test these interactions within the sick human preterm
infant population studied here, however the results of the present study can be used to inform
future studies in relevant animal models [59,60,61] in order to elucidate the mechanisms un-
derlying these correlations.
Future research should also investigate the mechanisms that give rise to the different inter-
actions and effects of the gasotransmitters in male versus female preterm neonates. As many of
the steroid hormone receptors (such as those for progesterone, estrogen and testosterone) are
located within the endothelium and smooth muscle layers of blood vessels, the sex hormones
Gasotransmitter Interactions in the Preterm Neonate
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may have influence over these vasoactive substances and the downstream signalling mecha-
nisms involved in microvascular dilatation in a sex-specific manner.
We hypothesised that rates of antenatal glucocorticoids may contribute to the differences in
CO levels and effect on blood flow observed in the present study compared to our previous
studies in a similar cohort [4]. Glucocorticoids, such as antenatally administered betametha-
sone can modulate blood pressure, vascular reactivity and the production and action of vaso-
constrictors and vasodilators, such as the gasotransmitters [62,63]. In mice, administration of
glucocorticoids reduces eNOS levels (through decreased transcription and increased degrada-
tion) in aorta, liver and kidney [64,65,66,67]. Dexamethasone is known to reduce the release of
NO from the endothelium and completely suppresses the inducible form of NOS [68,69,70,71].
Dexamethasone also downregulates HO-1 expression in models of systemic inflammation [72]
and suppresses CSE expression, reducing H2S production, both directly through regulation
of transcription and through inhibition of NO production, which is known to drive CSE
expression [24]. Glucocorticoids are also known to decrease other vasodilators, including
prostaglandins and enhance the effects of vasoconstrictors such as Angiotensin II [73,74] and
norepinephrine [63,75,76]. The effect of glucocorticoids on the levels of individual vasoactive
molecules, and overall vascular tone regulation, needs to be studied further in order to deter-
mine if antenatal glucocorticoid exposure effects gasotransmitters production and/or action in
the preterm newborn. This is particularly relevant in the context of sex differences in gaso-
transmitters-related regulation of vascular tone, as it is well characterised that males and fe-
males metabolise and respond to glucocorticoid exposure differently [48,77].
Future studies should also consider the effect of a range of other vasoactive inputs, such as
the sympathetic nervous system and the renin-angiotensin system and the newly identified
fourth gasotransmitter, ammonium [78]. The action of these pathways and their interaction
with the gasotransmitter system presented here may contribute to overall vascular tone regula-
tion in this vulnerable population.
Conclusions
We identified significant correlations between the gasotransmitters NO, CO and H2S and mi-
crovascular blood flow in preterm neonates. This allowed us to produce a theoretical model for
the regulation of microvascular tone in the preterm newborn by the action and interaction of
the gasotransmitters. The results of the present study suggest that CO may confer some protec-
tive advantage in the female preterm neonate whilst in the male neonate, H2S production may
be aberrantly modulated by NO, likely through changes in CSE expression. This hypothesis is
supported by the results of the present study, previous studies by others (see Table 1) and those
of ourselves—we have shown that CSE production is upregulated in the preterm newborn male
and that H2S produced via CSE (but not CSE-independent pathways) correlates with microvas-
cular tone dysregulation [56]. The relationship between NO and CSE/H2S is associated with
higher microvascular blood flow and may be of particular interest given the wealth of literature
surrounding an interaction between these two molecules (and their production pathways); fur-
ther work is required in order to confirm this. We present a theoretical model built on observa-
tions within a human population which provides evidence of gasotransmitters interactions in
the preterm newborn. This model provides a framework for establishing and testing current
and future mechanistic hypotheses within this population.
Supporting Information
S1 Data. Alternate Structural Equation Models. Alternate models were tested and are pre-
sented here. As in the manuscript, the interaction between the three gasotransmitters and their
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individual and combined effects on microvascular blood flow were assessed. All models were
manually constructed and presented here for our three input (NO, CO and H2S) and one out-
put (microvascular blood flow) variables. These models were then tested and assessed for suit-
ability by χ2 Goodness of Fit and root mean square error of approximation (RMSEA). Lower
χ2 values represent a better predicted model, whilst an RMSEA of below 0.06 shows a good fit.
RMSEA also allows for calculation of a confidence interval (CI) around the predictive power of
the model. None of these models had a more acceptable χ2 or RMSEA value and CI, thus the
selection of the model presented within the manuscript.
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